ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

New Cooperative Group Funded

September 30, 1977

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977